Ideas

Natural product-based therapy for Bone disorders: Genistein inhibits osteoporosis and bone metastasis via up regulation of its target gene, 28/July/2016, 7.45 am
Natural product-based therapy for Bone disorders: Genistein inhibits osteoporosis and bone metastasis via up regulation of its target gene, 28/July/2016, 7.45 am 150 150 Dr Boomi's Genom-2-Discovery Center

A study from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA has reported that “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.” This…

read more

Natural product-based Lifespan extension therapy: Berberine activates autophagy and extends lifespan via up regulation of ATG5, 26/July/2016, 8.44 am
Natural product-based Lifespan extension therapy: Berberine activates autophagy and extends lifespan via up regulation of ATG5, 26/July/2016, 8.44 am 150 150 Dr Boomi's Genom-2-Discovery Center

A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was published in the online journal “Nature communications” by Prof. Jung YK,…

read more

Interleukin therapy for Diabetes mellitus: IL-17 increases islet insulin levels, islet cell mass and glucose tolerance via down regulation of NMDA receptor GluN2A, 24/July/2016, 7. 04 am
Interleukin therapy for Diabetes mellitus: IL-17 increases islet insulin levels, islet cell mass and glucose tolerance via down regulation of NMDA receptor GluN2A, 24/July/2016, 7. 04 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How IL-17 decreases the expression of NMDA receptor GluN2A Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ A study from the Institute of Metabolic Physiology, Heinrich Heine University, Düsseldorf, Germany shows…

read more

Small molecule-based therapy for Intestinal cancer: UBTD1 increases the expression of DNA Sensor AIM2 and inhibits expansion of tumor-initiating intestinal stem cell population via up regulation of its target gene, 23/July/2015, 11.40 pm
Small molecule-based therapy for Intestinal cancer: UBTD1 increases the expression of DNA Sensor AIM2 and inhibits expansion of tumor-initiating intestinal stem cell population via up regulation of its target gene, 23/July/2015, 11.40 pm 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How UBTD1  increases the expression of tumor suppressor AIM2. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ A recent study from the Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN…

read more

Small RNA-based therapy for pulmonary arterial hypertension: MiRNA-7 inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 23/July/2015, 11.14 pm
Small RNA-based therapy for pulmonary arterial hypertension: MiRNA-7 inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 23/July/2015, 11.14 pm 150 150 Dr Boomi's Genom-2-Discovery Center

A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General Medicine with an…

read more

Regenerative Stem cell therapy for Myocardial Infarction: MiRNA-290 improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 23/July/2016, 14.35
Regenerative Stem cell therapy for Myocardial Infarction: MiRNA-290 improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 23/July/2016, 14.35 150 150 Dr Boomi's Genom-2-Discovery Center

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others. On the foundation of this…

read more
Start Typing